Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Enliven Therapeutics (ELVN) Q1 2021 Earnings
ELVN
11
May
Expected
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-2.32
-1.73
-1.15
-0.56
Details
Expected EPS
-0.835
Actual EPS
-2.32
Surprise EPS
-1.48
Surprise Percent
+177.84%
Description
Enliven Therapeutics (ELVN) has reported earnings of -2.32 per share for Q1 2021.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login